NANOLAST

Serial Number 97757784
Registration 7415453
700

Registration Progress

Application Filed
Jan 17, 2023
Under Examination
Mar 19, 2024
Approved for Publication
Jan 23, 2024
Published for Opposition
Jan 23, 2024
Registered
Jun 11, 2024

Trademark Image

NANOLAST

Basic Information

Serial Number
97757784
Registration Number
7415453
Filing Date
January 17, 2023
Registration Date
June 11, 2024
Published for Opposition
January 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 11, 2024
Registration
Registered
Classes
005

Rights Holder

Primera Compounding, LLC

16
Address
30444 SW Freeway, Building H
Rosenberg, TX 77471

Ownership History

Primera Compounding, LLC

Original Applicant
16
Rosenberg, TX

Primera Compounding, LLC

Owner at Publication
16
Rosenberg, TX

Primera Compounding, LLC

Original Registrant
16
Rosenberg, TX

Legal Representation

Attorney
Usha Menon

USPTO Deadlines

Next Deadline
1631 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240611)
Due Date
June 11, 2030
Grace Period Ends
December 11, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Jun 11, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 11, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 6, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 6, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 4, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 12, 2024 IUAF S USE AMENDMENT FILED Loading...
May 3, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 12, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 19, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 18, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 18, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 18, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 18, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 18, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 16, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 15, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 15, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 13, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 13, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 13, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 13, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 7, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug carriers for medical use, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medical and biological preparations, namely, ophthamics in the nature of pharmaceutical preparations for treatment of dry eyes and ocular surface diseases; pharmaceutical preparations for use in the treatment of dry eyes and ocular surface diseases
First Use Anywhere: Sep 20, 2023
First Use in Commerce: Sep 20, 2023

Classification

International Classes
005